Skin Diseases  >>  Tracleer (bosentan)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Tracleer (bosentan) / J&J, Roche
NCT00318175: Effect of Bosentan on Skin Fibrosis in Patients With Systemic Sclerosis

Completed
2
10
Europe
Bosentan (Tracleer)
Heinrich-Heine University, Duesseldorf
Systemic Scleroderma, Skin Fibrosis, Hand Functionality
 
05/07
NCT00377455: Placebo Controlled Trial of Bosentan in Scleroderma Patients

Terminated
2
5
US
Bosentan, Placebo
Georgetown University, Actelion
Systemic Scleroderma, Pulmonary Hypertension
09/09
03/10
NCT02317679: Treatment of Resistant Port-wine Stains With Bosentan and Pulsed Dye Laser: a Pilot Study

Completed
2
4
Europe
Bosentan, tracleer, Pulsed dye laser (PDL)
Centre Hospitalier Universitaire de Nice
Port-wine Stains
09/14
02/15
ScS-REINBO, NCT01241383 / 2010-021452-26: Effect of Bosentan in Scleroderma Renal Crisis

Completed
2
16
Europe
Bosentan
Assistance Publique - Hôpitaux de Paris, Actelion
Scleroderma Renal Crisis
10/15
06/16
TRANOS, NCT00226889: Treatment of Early Systemic Sclerosis by Bosentan

Terminated
1/2
30
Europe
bosentan
Rikshospitalet University Hospital
Systemic Sclerosis (Scleroderma)
01/09
06/09

Download Options